Findings from a new study on the efficacy of the advanced radioactive tracer Fluciclovine in radiation treatment have revealed that it significantly improves the chance of patient survival without the reoccurrence of cancer. This conclusion came after 75.5 percent of patients who had recurrent prostate cancer and were imaged with the radiotracer survived for three

Researchers tested Cerenkov luminescence imaging (CLI) in 10 high-risk prostate cancer patients, and they detected a residual tumor. The researchers were from the University Medical Center Essen in Germany. CLI can now be used for identifying cancerous cells during prostate cancer surgery. When surgeons miss cancerous cells during surgery, it increases the chances of reoccurrence

A positron emission tomography (PET-CT) is used to scan for cancer and to know more about its current stage.  A PET-CT scan is more specific than other imaging options. Doctors use it to check if the cancer treatment is working, plan for radiotherapy, and find the exact position for a biopsy. After your cancer treatment,

Positron Emission Tomography (PET) is an imaging method that works by tracking sugar uptake in both healthy and abnormal cells in the body. It enables radiologists to see body function (cell activity) and identify areas that are absorbing sugar. To determine the tissues that absorb high amounts of sugar, the patient is injected with a

The total body dynamic PET scans could be used to detect metastatic cancer successfully. Dynamic PET provides parametric images showing the actual behavior of the tissue. The parametric images can potentially help to detect lesions and evaluate the response of cancer to therapy.But this potential has not been within the clinic, as conventional PET scanners don’t

Lung cancer is caused by many factors, the most common being smoking. But now there’s good news for people at risk of the disease. A low-dose CT scan can help save their lives. Low dose CT scans, together with follow-up PET scans, can help remove nodules in the lungs early before they grow and progress.

Patients with total metabolic response on FDG-PET scan should get consideration with complete response. Those with a partial response on a CT scan and a complete metabolic response on FDG-PET scan should be considered to have achieved a low risk for melanoma relapse and complete response. Patients with metastatic melanoma treated with anti-PD1 immune checkpoint

Diagnosing and tracking tumors in patients with neuroendocrine cancer is quite challenging. However, a new pharmaceutical drug was approved for use with positron emission tomography (PET) to make rare tumors visible on medical imaging. Known as Gallium-68, or NETSpot, or Gallium Dotatate, the drug is used in PET-CT imaging of neuroendocrine tumors. PET scanning helps

One low-dose chest CT scan cannot cause significant human chromosomal DNA damage to a patient. In a study to measure biologic markers of DNA damage in blood samples taken before and after a chest scan, results showed that patients who received the low-dose CT scan did not have increased numbers of DNA double-strand breaks. However,

A PET-CT scan is vital in diagnosing cancer with accuracy. A new digital PET CT scanner offers high precision cancer diagnosis. This helps oncologists develop better treatment plans for patients. The digital PET CT is the first UDR detector that helps in identifying smaller lesions in the body. It improves the reproducibility, performance, and accuracy